Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397326
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-02
First Post:
2024-04-05
Brief Title:
Sustainable and Healthy Return-to-Work Program - PRATICAdr 20
Sponsor:
Université du Québec a Montréal
Organization:
Université du Québec a Montréal
Study Overview
Official Title:
Sustainable and Healthy Return-to-Work Program for Employees of Large Healthcare Organizations - PRATICAdr 20
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRATICAdr
Brief Summary:
This study aims to assess the effectiveness of PRATICAdr 20 a web application facilitated by a Return-to-Work Coordinator RTW-C with a focus on reducing sick leave duration and preventing relapse in individuals with CMDs PRATICAdr 20 designed to enhance collaboration among Return-to-Work RTW stakeholders and provide systematic support throughout the RTW process is evaluated in a randomized control trial RCT As part of the RCT a total of 80 sick leave employees from 4 large public health organizations n80 40 from the experimental group and 40 from the control group will be recruited The control group receives usual services offered by a RTW-C to sick leave employees while the experimental group receives RTW-C services plus the use of PRATICAdr 20
Detailed Description:
Common mental disorders CMDs are highly prevalent in workplace settings and have become a significant public health challenge This study aims to assess the effectiveness of PRATICAdr 20 a web application facilitated by a Return-to-Work Coordinator RTW-C with a focus on reducing sick leave duration and preventing relapse in individuals with CMDs PRATICAdr 20 designed to enhance collaboration among Return-to-Work RTW stakeholders and provide systematic support throughout the RTW process is evaluated in a randomized control trial RCT As part of the RCT a total of 80 sick leave employees from 4 large public health organizations n80 40 from the experimental group and 40 from the control group will be recruited The control group receives usual services offered by a RTW-C to sick leave employees while the experimental group receives RTW-C services plus the use of PRATICAdr 20 Participants will be randomly assigned to either the PRATICAdr 20 experimental group or the control group using computerized stratified randomization based on age site and sex sealed envelope method Participants will complete a series of online questionnaires at several following time points Survival analyses were used to compare sick leave durations and relapses between the experimental group PRATICAdr with RTW-C and control groups RTW-C only Mixed linear models were used to observe changes in clinical symptoms over time especially for the experimental group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None